 | • レポートコード：MRC23Q36168 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の腫瘍学用投薬管理市場について調査・分析し、世界の腫瘍学用投薬管理市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口、注射、塗抹）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、B. Braun Melsungen AG、Dana-Farber Cancer Institute、MedicoRx、McKesson Corporation、Kroger Specialty Pharmacyなどが含まれています。 世界の腫瘍学用投薬管理市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、腫瘍学用投薬管理市場規模を推定する際に考慮しました。本レポートは、腫瘍学用投薬管理の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、腫瘍学用投薬管理に関するビジネス上の意思決定に役立てることを目的としています。 ・腫瘍学用投薬管理市場の概要 - 腫瘍学用投薬管理のタイプ別セグメント - 世界の腫瘍学用投薬管理市場規模：タイプ別分析（経口、注射、塗抹） - 腫瘍学用投薬管理の用途別セグメント - 世界の腫瘍学用投薬管理市場規模：用途別分析（病院、クリニック、その他） - 世界の腫瘍学用投薬管理市場規模予測（2018年-2029年） ・腫瘍学用投薬管理市場の成長トレンド - 腫瘍学用投薬管理の地域別市場規模（2018年-2029年） - 腫瘍学用投薬管理市場ダイナミクス - 腫瘍学用投薬管理の業界動向 - 腫瘍学用投薬管理市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：経口、注射、塗抹 - 世界の腫瘍学用投薬管理のタイプ別市場規模（2018年-2023年） - 世界の腫瘍学用投薬管理のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界の腫瘍学用投薬管理の用途別市場規模（2018年-2023年） - 世界の腫瘍学用投薬管理の用途別市場規模（2024年-2029年） ・腫瘍学用投薬管理の地域別市場規模 - 北米の腫瘍学用投薬管理市場規模（2018年-2029年） - アメリカの腫瘍学用投薬管理市場規模（2018年-2029年） - ヨーロッパの腫瘍学用投薬管理市場規模（2018年-2029年） - アジア太平洋の腫瘍学用投薬管理市場規模（2018年-2029年） - 中国の腫瘍学用投薬管理市場規模（2018年-2029年） - 日本の腫瘍学用投薬管理市場規模（2018年-2029年） - 韓国の腫瘍学用投薬管理市場規模（2018年-2029年） - インドの腫瘍学用投薬管理市場規模（2018年-2029年） - オーストラリアの腫瘍学用投薬管理市場規模（2018年-2029年） - 中南米の腫瘍学用投薬管理市場規模（2018年-2029年） - 中東・アフリカの腫瘍学用投薬管理市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 B. Braun Melsungen AG、Dana-Farber Cancer Institute、MedicoRx、McKesson Corporation、Kroger Specialty Pharmacy ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Medication Management in Oncology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Medication Management in Oncology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medication Management in Oncology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Medication Management in Oncology in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Medication Management in Oncology include B. Braun Melsungen AG, Dana-Farber Cancer Institute, MedicoRx, McKesson Corporation and Kroger Specialty Pharmacy, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medication Management in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medication Management in Oncology.
The Medication Management in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medication Management in Oncology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medication Management in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
B. Braun Melsungen AG
Dana-Farber Cancer Institute
MedicoRx
McKesson Corporation
Kroger Specialty Pharmacy
Segment by Type
Oral
Injection
Smear
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medication Management in Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Management in Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Smear
1.3 Market by Application
1.3.1 Global Medication Management in Oncology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medication Management in Oncology Market Perspective (2018-2029)
2.2 Medication Management in Oncology Growth Trends by Region
2.2.1 Global Medication Management in Oncology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medication Management in Oncology Historic Market Size by Region (2018-2023)
2.2.3 Medication Management in Oncology Forecasted Market Size by Region (2024-2029)
2.3 Medication Management in Oncology Market Dynamics
2.3.1 Medication Management in Oncology Industry Trends
2.3.2 Medication Management in Oncology Market Drivers
2.3.3 Medication Management in Oncology Market Challenges
2.3.4 Medication Management in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication Management in Oncology Players by Revenue
3.1.1 Global Top Medication Management in Oncology Players by Revenue (2018-2023)
3.1.2 Global Medication Management in Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Medication Management in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medication Management in Oncology Revenue
3.4 Global Medication Management in Oncology Market Concentration Ratio
3.4.1 Global Medication Management in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Management in Oncology Revenue in 2022
3.5 Medication Management in Oncology Key Players Head office and Area Served
3.6 Key Players Medication Management in Oncology Product Solution and Service
3.7 Date of Enter into Medication Management in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication Management in Oncology Breakdown Data by Type
4.1 Global Medication Management in Oncology Historic Market Size by Type (2018-2023)
4.2 Global Medication Management in Oncology Forecasted Market Size by Type (2024-2029)
5 Medication Management in Oncology Breakdown Data by Application
5.1 Global Medication Management in Oncology Historic Market Size by Application (2018-2023)
5.2 Global Medication Management in Oncology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medication Management in Oncology Market Size (2018-2029)
6.2 North America Medication Management in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medication Management in Oncology Market Size by Country (2018-2023)
6.4 North America Medication Management in Oncology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medication Management in Oncology Market Size (2018-2029)
7.2 Europe Medication Management in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medication Management in Oncology Market Size by Country (2018-2023)
7.4 Europe Medication Management in Oncology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medication Management in Oncology Market Size (2018-2029)
8.2 Asia-Pacific Medication Management in Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medication Management in Oncology Market Size by Region (2018-2023)
8.4 Asia-Pacific Medication Management in Oncology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medication Management in Oncology Market Size (2018-2029)
9.2 Latin America Medication Management in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medication Management in Oncology Market Size by Country (2018-2023)
9.4 Latin America Medication Management in Oncology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication Management in Oncology Market Size (2018-2029)
10.2 Middle East & Africa Medication Management in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medication Management in Oncology Market Size by Country (2018-2023)
10.4 Middle East & Africa Medication Management in Oncology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Detail
11.1.2 B. Braun Melsungen AG Business Overview
11.1.3 B. Braun Melsungen AG Medication Management in Oncology Introduction
11.1.4 B. Braun Melsungen AG Revenue in Medication Management in Oncology Business (2018-2023)
11.1.5 B. Braun Melsungen AG Recent Development
11.2 Dana-Farber Cancer Institute
11.2.1 Dana-Farber Cancer Institute Company Detail
11.2.2 Dana-Farber Cancer Institute Business Overview
11.2.3 Dana-Farber Cancer Institute Medication Management in Oncology Introduction
11.2.4 Dana-Farber Cancer Institute Revenue in Medication Management in Oncology Business (2018-2023)
11.2.5 Dana-Farber Cancer Institute Recent Development
11.3 MedicoRx
11.3.1 MedicoRx Company Detail
11.3.2 MedicoRx Business Overview
11.3.3 MedicoRx Medication Management in Oncology Introduction
11.3.4 MedicoRx Revenue in Medication Management in Oncology Business (2018-2023)
11.3.5 MedicoRx Recent Development
11.4 McKesson Corporation
11.4.1 McKesson Corporation Company Detail
11.4.2 McKesson Corporation Business Overview
11.4.3 McKesson Corporation Medication Management in Oncology Introduction
11.4.4 McKesson Corporation Revenue in Medication Management in Oncology Business (2018-2023)
11.4.5 McKesson Corporation Recent Development
11.5 Kroger Specialty Pharmacy
11.5.1 Kroger Specialty Pharmacy Company Detail
11.5.2 Kroger Specialty Pharmacy Business Overview
11.5.3 Kroger Specialty Pharmacy Medication Management in Oncology Introduction
11.5.4 Kroger Specialty Pharmacy Revenue in Medication Management in Oncology Business (2018-2023)
11.5.5 Kroger Specialty Pharmacy Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details